SEC Company Response from Axcella Health Inc. (CIK 0001633070) — May 11, 2020
Axcella Health Inc. (CIK 0001633070)
Date: May 11, 2020 · CIK: 0001633070 · Accession: 0001104659-20-059639
AI Filing Summary & Sentiment
File numbers found in text: 333-238168
Letter
VIA EDGAR Division of Corporation Finance Acceleration Request for Registration Statement on Form S-1 File No. 333-238168 Requested Date: May 13, 2020 Requested Time: 4:00 p.m. Eastern Standard Time
Re: Axcella Health Inc.
Dear Mr. Fischer:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), J.P. Morgan Securities LLC and SVB Leerink LLC, as representatives of the several underwriters, hereby join Axcella Health Inc. in requesting that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to May 13, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.
We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable.
[Signature Page Follows]
Very truly yours,
As representatives of the several underwriters
Show Raw Text
CORRESP
1
filename1.htm
VIA EDGAR
May 11, 2020
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Paul Fischer
Re:
Axcella Health Inc.
Acceleration Request for Registration
Statement on Form S-1
File No. 333-238168
Requested Date:
May 13, 2020
Requested Time:
4:00 p.m. Eastern Standard Time
Dear Mr. Fischer:
In accordance with Rule 461 under the Securities
Act of 1933, as amended (the “Act”), J.P. Morgan Securities LLC and SVB Leerink LLC, as representatives of the
several underwriters, hereby join Axcella Health Inc. in requesting that the effective date of the above-referenced registration
statement (the “Registration Statement”) be accelerated to May 13, 2020, at 4:00 p.m., Eastern Time, or as soon
thereafter as practicable.
Pursuant to Rule 460 under the Act, please
be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to underwriters, dealers,
institutions and others, prior to the requested effective time of the Registration Statement.
We have been informed by the participating
underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended,
to the extent applicable.
[Signature Page Follows]
Very truly yours,
As representatives of the several underwriters
J.P. MORGAN SECURITIES LLC
By:
/s/ David Ke
Name: David Ke
Title: Executive Director
SVB LEERINK LLC
By:
/s/ Stuart R. Nayman
Name: Stuart R. Nayman
Title: Managing Director